Intracellular enzymes in erythrocytes can be made accessible for in situ kinetic studies by treating the cells with bifunctional reagents to crosslink proteins, thus creating a network that allows subsequent permeabilization by delipidation without escape of intracellular proteins. Dimethyl suberimidate, dimethyl 3,3'-dithiobispropionimidate, and toluene-2,4-diisocyanate have been used successfully as crosslinking reagents, and digitonin has been used for delipidation. In a systematic study of the in situ behavior of the 11 glycolytic enzymes of rat erythrocytes, it was observed that Km and Vma,
photransferase, EC 2.7.1.1) was allosterically inhibited by glucose 6-phosphate nearly as much in situ as in vitro but was not affected by 2,3-bisphosphoglycerate. The Many intracellular enzymes are present in high concentrations (1) . Protein-protein interactions, both homologous (2) and heterologous (3) , could induce intracellular changes in some properties of the enzymes important for metabolic regulation. For these reasons it can be said that in vitro studies of kinetic parameters of potential significance for metabolic regulation, particularly with allosteric enzymes, should be considered as guidelines to studies "when techniques are available to study control of enzymes in situ" (4) . The in situ approach for the kinetic study of enzymes in cells has been proposed; it could be easily accomplished in microorganisms endowed with a cell wall (5) (6) (7) .
A general method for the kinetic study of enzymes in animal cells based on crosslinking with bifunctional reagents and permeabilization with digitonin is presented here. With this approach we have carried out a systematic exploration of the kinetic behavior of the 11 enzymes of glycolysis in erythrocytes.
The results indicate that Km and Vn,, are essentially the same in situ (in permeabilized cells) as in vitro and, hence, presumably in vivo; however, the kinetic parameters of phosphofructokinase and certain other allosteric enzymes in situ show important differences from those observed in vitro. Preliminary reports of part of this work have been presented (8, 9 Erythrocytes. Blood was obtained from Swiss albino rats and occasionally from human volunteers; heparin was used to prevent coagulation.
Crosslinking and Permeabilization of Erythrocytes. Fresh blood (2 ml) was diluted with -10 ml of buffer E and centrifuged at low speed (10,000 X g for 5 min); the plasma and bluffy coat were removed by suction. After a second wash with buffer E, the erythrocytes were treated with one of the crosslinking reagents, as follows.
Dimethyl suberimidate. Forty milligrams of dimethyl suberimidate dihydrochloride was dissolved in 7 ml of 100 mM triethanolamine, pH 8.5/75 mM NaCl and 0.26 ml of 1 M NaOH and mixed immediately with the washed erythrocytes; the mixture was allowed to stand at 37°C for 30 min. After centrifugation at 1000 X g for 5 min, the supernatant solution was removed and the sediment was washed with 10 ml of buffer E. The washed cells obtained by centrifugation were suspended in a mixture of 20 ml of water and 1 ml of 1% digitonin in ethanol, allowed to stand for 5 min at room temperature, centrifuged, washed with 10 ml of buffer I, and finally resuspended in a convenient volume of the same buffer.
DTBP. Ten milligrams of DTBP dihydrochloride was dissolved in 8 ml of 50 mM Tris-HCI, pH 9.0/125 mM NaCl and mixed immediately with the washed erythrocytes obtained from 2 ml of blood. After 30 min at 37°C the cells were treated as indicated above.
Toluene diisocyanate. A fine emulsion at 0.5% in buffer E was prepared by sonication. Three milliliters of this fresh emulsion was added to 20 ml of a suspension, in buffer E at 4°C, of washed erythrocytes obtained from 2 ml of blood. The mixture was stored for 3 min and then the process was continued as above.
ASSAY OF ENZYMES IN SITU
Permeabilized cells were suspended [ (12) . RESULTS
The use of toluene diisocyanate and DTBP to crosslink proteins in erythrocytes has been described (13, 14) . Rat The effect of the concentration of pyruvate on the activity of lactate dehydrogenase was the same in situ as in vitro (Fig.  1) , including the inhibition by excess pyruvate (16) . This result gives direct evidence that the H isozyme of lactate dehydrogenase can be inhibited in the cells (although by unphysiological concentrations of pyruvate), despite claims to the contrary on the basis of experiments in vitro with high concentrations of the enzyme alone or in the presence of some other proteins (17) .
Vmax and Km Values in Situ. The Vmax of each of the glycolytic enzymes in situ was 30 to 60% of that in vitro (Table 1) in otherwise identical conditions of assay, with an average of roughly 50%. Losses of 90% or more of the activities of phosphoglycerate kinase, phosphoglyceromutase, and pyruvate kinase were observed after treatment with toluene diisocyanate, making this reagent unsuitable for kinetic studies with these enzymes. Treatment of hemolysates with the corresponding bifunctional reagents led to losses within a factor of 2 of those in situ, with an average loss of 43% for the 11 In the reverse reaction with respect to glycolysis. § Numbers in parentheses are the values in the presence of positive effectors. ¶ Gra, glyceraldehyde; Gri, glycerate corresponding to a substrate or coenzyme that gives in vitro hyperbolic kinetics, were also essentially the same as in vitro. One exception was the Km of hexokinase for ATP, which in situ had two values, 0.15 and 1.5 mM, instead of the 0.3 mM value obtained in vitro.
Allosteric Parameters in Situ. In contrast with the above results for nonallosteric enzymes, the allosteric effects in situ were quantitatively different from those in vitro in several instances.
Hexokinase is inhibited allosterically by glucose 6-phosphate in vitro (18) and in vivo (19) . The enzyme appeared to be somewhat less strongly inhibited in situ than in vitro, with Ki values of 0.07 and 0.04 mM, respectively. The isotopic method allowed the observation in the intermediate situation of an "undiluted" hemolysate (involving only -50% dilution between extracellular fluid and reaction mixture), which gave an intermediate value (Ki, 0.05 mM). Nevertheless, these small differences may not be significant because of potential interference by removal of hexose 6-phosphate by phosphofructokinase which, as shown below, was found to be more active in situ than in vitro, in the conditions used for the hexokinase assay. 2,3-Bisphosphoglycerate has also been reported as an assumed physiological inhibitor of erythrocyte hexokinase (20, 21) . Nevertheless, in our more physiological conditions, we have found no significant inhibition (less than 5%) either in situ or in vitro, with up to 2.5 mM 2,3-bisphosphoglycerate, a concentration in the upper range of this metabolite uncomplexed to hemoglobin in erythrocytes (22) .
Phosphofructokinase is a highly sophisticated regulatory enzyme, the main control point in glycolysis (23, 24) and kinetically sensitive to the concentration of the enzyme (2) . The enzyme has markedly sigmoidal kinetics with respect to fructose 6-phosphate in the absence of positive effectors. These are changed to hyperbolic kinetics by the synergistic positive effectors AMP, Pi, and NH+. A smaller contrast between the two conditions was found in situ. The So. Crosslinking with DTBP resulted in a similar picture and gave the opportunity to observe the effect of the chemical modification, after the crosslink was broken with dithioerythritol. The results shown in Fig. 2 were essentially identical with those obtained with dimethyl suberimidate-treated cells or hemolysates. The remaining differences between the curves in the absence of effectors before and after lysis presumably correspond to the high concentration of the enzyme in the cell. The noninhibitory phosphoryl donor MgITP gave hyperbolic kinetics with the same Km value in situ and in vitro (Table 1) Fructose-6-P, mM to a smaller extent than in vitro. The Ki values obtained at pH 7.4 were 0.9 and 0.4 mM, respectively, and at pH 6.9 they were 0.5 and 0.03 mM, respectively.
Glyceraldehyde-phosphate dehydrogenase represents a classical example of homotropic cooperativity (25) , although it is unlikely to be involved in metabolic regulation (24) . In situ studies of this enzyme yielded, for NAD+, values of SO.5 of 0.18 mM and n of 2.6, compared to SO.5 of 0.05 mM and n of 1.6 in vitro.
The pyruvate kinase of erythrocytes is a slight posttranslational modification of the L isozyme (26) , itself a multimodulated enzyme (23) . The saturation curves for phosphoenolpyruvate in situ and in vitro in the absence and presence of the activator fructose 1,6-bisphosphate are shown in Fig. 3 (Fig. 2) (40) . The in situ approach for study of the physiological behavior of enzymes should be complemented with in vitro studies under more physiological conditions.
